Technical Analysis for MDXH - MDxHealth SA

Grade Last Price % Change Price Change
F 9.13 1.44% 0.13
MDXH closed up 1.44 percent on Tuesday, December 7, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical MDXH trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 1.44%
Hot IPO Pullback Bullish Swing Setup 1.44%
Wide Bands Range Expansion 1.44%
Down 3 Days in a Row Weakness 1.44%
Oversold Stochastic Weakness 1.44%
Wide Bands Range Expansion -0.33%
Oversold Stochastic Weakness -0.33%
Hot IPO Pullback Bullish Swing Setup -2.25%
Older End-of-Day Signals for MDXH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 15 hours ago
Gap Up Closed about 16 hours ago
Gap Up Partially Closed about 16 hours ago
10 DMA Support about 16 hours ago
Gapped Up (Full) about 16 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


MDxHealth SA Description

MDxHealth SA operates as a molecular diagnostics company in Belgium, the Netherlands, Spain, Poland, Italy, the United States, rest of European Union, and internationally. The company develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. Its tests are based on proprietary genetic, epigenetic, and other molecular technologies, as well as assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's product pipeline includes tests for bladder, kidney, and other urologic cancers. Its products include ConfirmMDx, a tissue test for prostate cancer; and SelectMDx, a non-invasive urine test for prostate cancer. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Cancer Clinical Medicine Prostate Cancer Medical Genetics Urology Molecular Diagnostics Molecular Technologies

Is MDXH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 13.17
52 Week Low 8.79
Average Volume 58,476
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 10.06
10-Day Moving Average 9.24
Average True Range 0.72
ADX 0.0
+DI 10.24
-DI 25.11
Chandelier Exit (Long, 3 ATRs) 10.11
Chandelier Exit (Short, 3 ATRs) 10.95
Upper Bollinger Bands 11.85
Lower Bollinger Band 8.27
Percent B (%b) 0.24
BandWidth 35.61
MACD Line -0.79
MACD Signal Line -0.61
MACD Histogram -0.1805
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.21
Resistance 3 (R3) 10.29 10.00 10.03
Resistance 2 (R2) 10.00 9.73 9.97 9.97
Resistance 1 (R1) 9.57 9.56 9.43 9.49 9.91
Pivot Point 9.28 9.28 9.21 9.25 9.28
Support 1 (S1) 8.85 9.01 8.71 8.77 8.35
Support 2 (S2) 8.56 8.84 8.53 8.29
Support 3 (S3) 8.13 8.56 8.23
Support 4 (S4) 8.05